Antioxidants and cisplatin nephrotoxicity; an updated review on current knowledge
Cisplatin is a first-line antitumor drug which is applied in the therapeutic field of numerous kinds of cancers. The main dose-dependent adverse effect of cisplatin is nephrotoxicity in approximately one-third of patients, who received this drug during their treatment. Oxidative stress is one of the...
Saved in:
Main Authors: | Ramin Tolouian (Author), Audrey Tolouian (Author), Farzaneh Dastan (Author), Vida Farhangi (Author), Payam Peymani (Author), Sanam Saeifar (Author), Oscar Felipe Borja Montes (Author), Leila Mohmoodnia (Author), Mohammadreza Khosravifarsani (Author), Tella Sadighpour (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of metformin in chronic kidney disease-mineral and bone disorder
by: Rohollah Masumi, et al.
Published: (2021) -
Herbal antioxidants and renal ischemic-reperfusion injury; an updated review
by: Masoumeh Asgharpour, et al.
Published: (2021) -
Lung cancer and kidney injury: an updated review
by: Bhargav Patel, et al.
Published: (2021) -
Epigenetic Mechanisms Involved in Cisplatin-Induced Nephrotoxicity: An Update
by: Pía Loren, et al.
Published: (2021) -
Systemic lupus erythematosus following SARS-CoV-2 vaccination; a review of literature
by: Leila Mahmoudnia, et al.
Published: (2023)